Rasmus Hoeg is an Oncology physician affiliated with City of Hope. OpenAlex indexes 94 publications with 365 citations (h-index 10).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4501 X Street, Suite 3016
Sacramento, CA 958172229
Telephone
916-734-5981Registry record last updated 29 Aug 2019.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- SANOFI-AVENTIS U.S. LLCProgram year20221 payment
- Kite Pharma, Inc.Program year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
21.8%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor21.8%Acyclovir100%Part D≥33 patientsCancer & immunology
21.1%Kinase inhibitor13.7%Jakafi67%Bosulif17%Iclusig17%Part D<11 patientsBCL-2 Inhibitor5.3%Venclexta100%Part D<11 patients+ 1 more class in this area
Anti-infectives
19.8%Azole Antifungal8.1%Posaconazole100%Part D≥11 patientsHerpesvirus Nucleoside Analog DNA Polymerase Inhibitor4.4%Valacyclovir100%Part D<11 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Hematopoietic Cell Transplantation, Version 3.2025, NCCN Clinical Practice Guidelines In Oncology
Journal of the National Comprehensive Cancer Network
2025 - Preliminary Safety and Efficacy of Myeloablative Orca-Q with No GvHD Prophylaxis for Treatment of Advanced Hematologic Malignancies
Biology of Blood and Marrow Transplantation
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Hope Rugo, MD
City of Hope
James Ito, MD
City of Hope
Victoria Seewaldt
City of Hope
Dean Lim, MD
City of Hope
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”